Profound Medical Company Executives
| PRN Stock | CAD 7.66 0.11 1.42% |
Profound Medical employs about 142 people. The company is managed by 10 executives with a total tenure of roughly 332 years, averaging almost 33.0 years of service per executive, having 14.2 employees per reported executive. Analysis of Profound Medical's management performance can provide insight into the firm performance.
Profound |
Profound Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.3854) % which means that it has lost $0.3854 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6636) %, meaning that it generated substantial loss on money invested by shareholders. Profound Medical's management efficiency ratios could be used to measure how well Profound Medical manages its routine affairs as well as how well it operates its assets and liabilities.Profound Medical Workforce Comparison
Profound Medical Corp is regarded second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 420. Profound Medical totals roughly 142 in number of employees claiming about 34% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.26) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.26. Profound Medical Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Profound Medical Corp Price Series Summation is a cross summation of Profound Medical price series and its benchmark/peer.
Profound Medical Notable Stakeholders
A Profound Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Profound Medical often face trade-offs trying to please all of them. Profound Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Profound Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Arun MBA | Chairman CEO | Profile | |
| Hartmut Warnken | Senior Alliances | Profile | |
| Jacques Cornet | Senior Sonalleve | Profile | |
| Stephen Kilmer | Investor Relations | Profile | |
| Mathieu Burtnyk | Senior TULSAPRO | Profile | |
| Thomas MBA | Chief Officer | Profile | |
| Abbey Goodman | Chief Global | Profile | |
| Levant Tinaz | Software Developer | Profile | |
| Michael Mydra | VP Access | Profile | |
| Rashed Dewan | Chief Officer | Profile |
About Profound Medical Management Performance
The success or failure of an entity such as Profound Medical Corp often depends on how effective the management is. Profound Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Profound management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Profound management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. PROFOUND MEDICAL operates under Diagnostics Research classification in Canada and is traded on Toronto Stock Exchange. It employs 64 people.
Profound Medical Workforce Analysis
Traditionally, organizations such as Profound Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Profound Medical within its industry.Profound Medical Manpower Efficiency
Return on Profound Medical Manpower
| Revenue Per Employee | 75.2K | |
| Revenue Per Executive | 1.1M | |
| Net Loss Per Employee | 195.9K | |
| Net Loss Per Executive | 2.8M | |
| Working Capital Per Employee | 440.1K | |
| Working Capital Per Executive | 6.2M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.